Dusina, Alex
 Distribuzione geografica
Continente #
NA - Nord America 437
EU - Europa 329
AS - Asia 139
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 913
Nazione #
US - Stati Uniti d'America 430
SE - Svezia 97
IT - Italia 86
SG - Singapore 57
CN - Cina 44
FI - Finlandia 33
IE - Irlanda 28
DE - Germania 22
FR - Francia 19
ID - Indonesia 17
IN - India 13
GB - Regno Unito 10
RU - Federazione Russa 7
CA - Canada 6
AT - Austria 4
BE - Belgio 4
CI - Costa d'Avorio 4
PL - Polonia 4
ES - Italia 3
IR - Iran 3
RO - Romania 3
HK - Hong Kong 2
LT - Lituania 2
MD - Moldavia 2
NL - Olanda 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
MX - Messico 1
PT - Portogallo 1
VN - Vietnam 1
Totale 913
Città #
Chandler 163
Singapore 49
Milan 41
Ashburn 37
Helsinki 33
Dublin 26
Rome 24
New York 20
Jakarta 17
San Mateo 17
Boston 16
Princeton 16
Marseille 12
Wilmington 11
Beijing 8
Los Angeles 6
London 5
Moscow 5
Pune 5
Redwood City 5
Seattle 5
Abidjan 4
Brussels 4
Munich 4
Toronto 4
Vienna 4
Warsaw 4
Andover 3
Bologna 3
Bremen 3
Cambridge 3
Fairfield 3
Falkenstein 3
Frankfurt am Main 3
Nanjing 3
Woodbridge 3
Augusta 2
Brescia 2
Dearborn 2
Edinburgh 2
Las Vegas 2
Madrid 2
Norwalk 2
Ottawa 2
Paris 2
Sacramento 2
San Francisco 2
Siena 2
Amsterdam 1
Ann Arbor 1
Bend 1
Boardman 1
Bucharest 1
Canary Wharf 1
Chicago 1
Chisinau 1
Copenhagen 1
Dong Ket 1
Fayetteville 1
Florence 1
Fuzhou 1
Granada 1
Guangzhou 1
Hefei 1
Jiaxing 1
Jinan 1
Kaohsiung City 1
Kashan 1
Kish 1
Lisbon 1
Mexico City 1
Phoenix 1
Prineville 1
Riano 1
Santa Clara 1
Shanwei 1
São Paulo 1
Taipei 1
Wuxi 1
Zanjan 1
Zurich 1
Totale 629
Nome #
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice 78
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 77
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 73
Efficacy and safety of raltegravir in switch strategies in virologically suppressed patients: long-term data from clinical practice 72
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 61
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 61
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice 59
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 59
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 55
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 55
SARS-CoV-2 infection in a highly experienced person living with HIV 54
Virological outcomes with dolutegravir plus either lamivudine or two NRTIs as switch strategies: a multi-cohort study 47
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database 44
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 40
Short Communication: Efficacy and Safety of Dolutegravir plus Lamivudine as a First-Line Regimen in Clinical Practice 36
No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir 33
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients during Lamivudine plus Dolutegravir Maintenance Therapy in Clinical Practice 32
Totale 936
Categoria #
all - tutte 5.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.564


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 0 0 0 0 0 0 1 1 1 2 9 0
2020/202136 1 0 0 0 1 0 8 0 3 14 4 5
2021/2022114 1 1 0 7 0 2 10 22 5 5 15 46
2022/2023412 49 62 19 60 33 45 22 46 45 4 26 1
2023/2024193 13 40 0 17 8 34 15 6 5 9 27 19
2024/2025157 8 4 59 14 40 31 1 0 0 0 0 0
Totale 936